No effective treatments for CIP/CIM are currently available; therapies including nutritional interventions, antioxidant therapy, testosterone and growth hormone therapy, and immunoglobulin are potentially beneficial to CIP/CIM (Hermans et al., 2008). Here, GH1 is linked to hereditary sensory and autonomic neuropathy.